SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000819050-23-000054
Filing Date
2023-07-21
Accepted
2023-07-21 08:02:06
Documents
17
Period of Report
2023-07-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K frtx-20230721.htm   iXBRL 8-K 33162
2 EX-10.1 a202307218kex101.htm EX-10.1 56617
3 EX-10.2 a202307218kex102.htm EX-10.2 15323
4 EX-99.1 a202307218kex991.htm EX-99.1 12410
8 frtx-20230721_g1.jpg GRAPHIC 29102
9 image_0.jpg GRAPHIC 26867
  Complete submission text file 0000819050-23-000054.txt   367006

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT frtx-20230721.xsd EX-101.SCH 1905
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT frtx-20230721_lab.xml EX-101.LAB 25156
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT frtx-20230721_pre.xml EX-101.PRE 13052
11 EXTRACTED XBRL INSTANCE DOCUMENT frtx-20230721_htm.xml XML 2826
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 231101124
SIC: 2836 Biological Products, (No Diagnostic Substances)